期刊
LIFE-BASEL
卷 13, 期 8, 页码 -出版社
MDPI
DOI: 10.3390/life13081731
关键词
PTSD; pharmacological treatment; hypothalamic-pituitary-adrenal axis; opioids; glutamate; cannabinoids; oxytocin; microRNA
Post-traumatic stress disorder (PTSD) is a complex and challenging psychopathological condition with a heterogeneous clinical picture. The current pharmacological treatments for PTSD are mainly empirical and based on the serotonergic system, but they show only partial benefits due to limited knowledge of its neurobiology. New pathogenetic hypotheses, including different mediators and pathways, are urgently needed for the development of novel and more efficient drugs.
Post-traumatic stress disorder (PTSD) is a psychopathological condition with a heterogeneous clinical picture that is complex and challenging to treat. Its multifaceted pathophysiology still remains an unresolved question and certainly contributes to this issue. The pharmacological treatment of PTSD is mainly empirical and centered on the serotonergic system. Since the therapeutic response to prescribed drugs targeting single symptoms is generally inconsistent, there is an urgent need for novel pathogenetic hypotheses, including different mediators and pathways. This paper was conceived as a narrative review with the aim of debating the current pharmacological treatment of PTSD and further highlighting prospective targets for future drugs. The authors accessed some of the main databases of scientific literature available and selected all the papers that fulfilled the purpose of the present work. The results showed that most of the current pharmacological treatments for PTSD are symptom-based and show only partial benefits; this largely reflects the limited knowledge of its neurobiology. Growing, albeit limited, data suggests that the hypothalamic-pituitary-adrenal axis, opioids, glutamate, cannabinoids, oxytocin, neuropeptide Y, and microRNA may play a role in the development of PTSD and could be targeted for novel treatments. Indeed, recent research indicates that examining different pathways might result in the development of novel and more efficient drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据